Unknown

Dataset Information

0

Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.


ABSTRACT: BACKGROUND:Development of countermeasures to bioterrorist threats such as those posed by the smallpox virus (variola), include vaccination and drug development. Selective activation of nucleoside analogues by virus-encoded thymidine (dThd) kinases (TK) represents one of the most successful strategies for antiviral chemotherapy as demonstrated for anti-herpes drugs. Vaccinia virus TK is a close orthologue of variola TK but also shares a relatively high sequence identity to human type 2 TK (hTK), thus achieving drug selectivity relative to the host enzyme is challenging. RESULTS:In order to identify any differences compared to hTK that may be exploitable in drug design, we have determined the crystal structure of VVTK, in complex with thymidine 5'-triphosphate (dTTP). Although most of the active site residues are conserved between hTK and VVTK, we observe a difference in conformation of residues Asp-43 and Arg-45. The equivalent residues in hTK hydrogen bond to dTTP, whereas in subunit D of VVTK, Asp-43 and Arg-45 adopt a different conformation preventing interaction with this nucleotide. Asp-43 and Arg-45 are present in a flexible loop, which is disordered in subunits A, B and C. The observed difference in conformation and flexibility may also explain the ability of VVTK to phosphorylate (South)-methanocarbathymine whereas, in contrast, no substrate activity with hTK is reported for this compound. CONCLUSION:The difference in conformation for Asp-43 and Arg-45 could thus be used in drug design to generate VVTK/Variola TK-selective nucleoside analogue substrates and/or inhibitors that have lower affinity for hTK.

SUBMITTER: El Omari K 

PROVIDER: S-EPMC1636055 | biostudies-literature | 2006 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.

El Omari Kamel K   Solaroli Nicola N   Karlsson Anna A   Balzarini Jan J   Stammers David K DK  

BMC structural biology 20061024


<h4>Background</h4>Development of countermeasures to bioterrorist threats such as those posed by the smallpox virus (variola), include vaccination and drug development. Selective activation of nucleoside analogues by virus-encoded thymidine (dThd) kinases (TK) represents one of the most successful strategies for antiviral chemotherapy as demonstrated for anti-herpes drugs. Vaccinia virus TK is a close orthologue of variola TK but also shares a relatively high sequence identity to human type 2 TK  ...[more]

Similar Datasets

| S-EPMC5522336 | biostudies-literature
| S-EPMC1855528 | biostudies-literature
| S-EPMC7016767 | biostudies-literature
| S-EPMC3136756 | biostudies-literature
| S-EPMC3101437 | biostudies-literature
| S-EPMC7650665 | biostudies-literature
| S-EPMC3855713 | biostudies-literature
| S-EPMC10783082 | biostudies-literature
| S-EPMC4505040 | biostudies-literature
| S-EPMC3619541 | biostudies-literature